Clearpoint Neuro Stock Price on April 15, 2024
| CLPT Stock | USD 15.55 0.89 6.07% |
Below is the normalized historical share price chart for Clearpoint Neuro extending back to May 21, 2012. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Clearpoint Neuro stands at 15.55, as last reported on the 22nd of December, with the highest price reaching 15.78 and the lowest price hitting 14.29 during the day.
If you're considering investing in Clearpoint Stock, it is important to understand the factors that can impact its price. Clearpoint Neuro appears to be somewhat reliable, given 3 months investment horizon. Clearpoint Neuro secures Sharpe Ratio (or Efficiency) of 0.13, which signifies that the company had a 0.13% return per unit of standard deviation over the last 3 months. By analyzing Clearpoint Neuro's technical indicators, you can evaluate if the expected return of 0.56% is justified by implied risk. Please makes use of Clearpoint Neuro's mean deviation of 3.25, and Risk Adjusted Performance of 0.0922 to double-check if our risk estimates are consistent with your expectations.
At this time, Clearpoint Neuro's Common Stock Shares Outstanding is comparatively stable compared to the past year. Total Stockholder Equity is likely to gain to about 22.2 M in 2024, whereas Capital Stock is likely to drop slightly above 213.1 K in 2024. . At this time, Clearpoint Neuro's Price To Sales Ratio is comparatively stable compared to the past year. Price Book Value Ratio is likely to gain to 8.29 in 2024, whereas Price To Operating Cash Flows Ratio is likely to drop (12.79) in 2024. Clearpoint Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 12th of February 2020 | 200 Day MA 9.0699 | 50 Day MA 12.9108 | Beta 1.108 |
Clearpoint |
Sharpe Ratio = 0.1264
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | CLPT | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.39 actual daily | 39 61% of assets are more volatile |
Expected Return
| 0.56 actual daily | 11 89% of assets have higher returns |
Risk-Adjusted Return
| 0.13 actual daily | 9 91% of assets perform better |
Based on monthly moving average Clearpoint Neuro is performing at about 9% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Clearpoint Neuro by adding it to a well-diversified portfolio.
Price Book 14.7858 | Enterprise Value Ebitda (7.07) | Price Sales 14.092 | Shares Float 25.4 M | Wall Street Target Price 17 |
Clearpoint Neuro Main Headline on 15th of April 2024
Disposition of 1730 shares by Stigall L. Jeremy of Clearpoin... by Stigall L. Jeremy
Filed transaction by Clearpoint Neuro Officer Gm, Biologics Drug Delivery. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3
Clearpoint Neuro Valuation on April 15, 2024
It is possible to determine the worth of Clearpoint Neuro on a given historical date. On April 15, 2024 Clearpoint was worth 5.93 at the beginning of the trading date compared to the closed value of 5.61. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Clearpoint Neuro stock. Still, in general, we apply an absolute valuation method to find Clearpoint Neuro's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Clearpoint Neuro where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Clearpoint Neuro's related companies.
| Open | High | Low | Close | Volume | |
| 6.16 | 6.23 | 5.72 | 5.81 | 194,346 | |
04/15/2024 | 5.93 | 6.09 | 5.35 | 5.61 | 304,738 |
| 5.55 | 5.77 | 5.52 | 5.58 | 113,266 |
| Backtest Clearpoint Neuro | | | Clearpoint Neuro History | | | Clearpoint Neuro Valuation | Previous | Next |
Clearpoint Neuro Trading Date Momentum on April 15, 2024
| On April 16 2024 Clearpoint Neuro was traded for 5.58 at the closing time. The top price for the day was 5.77 and the lowest listed price was 5.52 . The trading volume for the day was 113.3 K. The trading history from April 16, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 0.53% . The overall trading delta against the current closing price is 6.06% . |
Clearpoint Neuro Fundamentals Correlations and Trends
By evaluating Clearpoint Neuro's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Clearpoint Neuro's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Clearpoint financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Clearpoint Neuro Stock history
Clearpoint Neuro investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Clearpoint is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Clearpoint Neuro will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Clearpoint Neuro stock prices may prove useful in developing a viable investing in Clearpoint Neuro
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 24.6 M | 25.8 M | |
| Net Loss | -14.8 M | -14.1 M |
Clearpoint Neuro Quarterly Net Working Capital |
|
Clearpoint Neuro Stock Technical Analysis
Clearpoint Neuro technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Clearpoint Neuro Period Price Range
Low | December 22, 2024
| High |
0.00 | 0.00 |
Clearpoint Neuro cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Clearpoint Neuro December 22, 2024 Market Strength
Market strength indicators help investors to evaluate how Clearpoint Neuro stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Clearpoint Neuro shares will generate the highest return on investment. By undertsting and applying Clearpoint Neuro stock market strength indicators, traders can identify Clearpoint Neuro entry and exit signals to maximize returns
Clearpoint Neuro Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Clearpoint Neuro's price direction in advance. Along with the technical and fundamental analysis of Clearpoint Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Clearpoint to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0922 | |||
| Jensen Alpha | 0.4269 | |||
| Total Risk Alpha | 0.338 | |||
| Sortino Ratio | 0.1109 | |||
| Treynor Ratio | 0.2853 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Clearpoint Stock Analysis
When running Clearpoint Neuro's price analysis, check to measure Clearpoint Neuro's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Clearpoint Neuro is operating at the current time. Most of Clearpoint Neuro's value examination focuses on studying past and present price action to predict the probability of Clearpoint Neuro's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Clearpoint Neuro's price. Additionally, you may evaluate how the addition of Clearpoint Neuro to your portfolios can decrease your overall portfolio volatility.